Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma
Clinical trial NCT04387500 · UNKNOWN
Trial details
- NCT number
- NCT04387500
- Sponsor
- West China Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-01
- Primary completion
- 2025-03-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.